Encompass Health Co. (NYSE:EHC) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. trimmed its holdings in shares of Encompass Health Co. (NYSE:EHC) by 7.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 528,061 shares of the company’s stock after selling 43,958 shares during the period. Victory Capital Management Inc. owned approximately 0.52% of Encompass Health worth $48,766,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. TD Private Client Wealth LLC lifted its position in Encompass Health by 2,870.0% during the third quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock valued at $709,000 after purchasing an additional 7,089 shares during the period. Los Angeles Capital Management LLC lifted its holdings in shares of Encompass Health by 532.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after buying an additional 42,338 shares during the period. Pathstone Holdings LLC boosted its stake in shares of Encompass Health by 54.5% in the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after buying an additional 7,412 shares during the last quarter. Meeder Asset Management Inc. grew its holdings in Encompass Health by 43.8% during the third quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock worth $6,417,000 after acquiring an additional 20,242 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Encompass Health by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after acquiring an additional 20,547 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on EHC. KeyCorp raised their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $107.67.

Encompass Health Price Performance

Shares of Encompass Health stock opened at $99.20 on Friday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The business has a 50 day simple moving average of $96.95 and a two-hundred day simple moving average of $96.74. The stock has a market capitalization of $9.99 billion, a P/E ratio of 22.24, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 12 month low of $74.27 and a 12 month high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health’s payout ratio is 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.